🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
This study is a Phase 1b/2 multi-center study to assess the safety, tolerab...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2020-06-22
Trial ID
NCT04492033
Treatments Being Tested
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
This is a first in human (FIH), Phase 1, dose escalation and expansion stud...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2026-04-21
Trial ID
NCT07612176
Treatments Being Tested
Multiple myeloma is a cancer of the plasma cells in the bone marrow. The m...
Status
Recruiting
Location
Infirmary Health - Diagnostic & Medical Clinic (DMC)
Start Date
2026-01-14
Trial ID
NCT06980480
Treatments Being Tested
The purpose of this study is to confirm the safety and tolerability of elra...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2021-03-22
Trial ID
NCT04798586
Treatments Being Tested
This is a Phase 1a/1b, open-label, dose escalation and expansion study to e...
Status
Recruiting
Location
University of Arkansas Winthrop P. Rockefeller Cancer Institute
Start Date
2024-07-10
Trial ID
NCT06515613
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
The object of this trial is to test whether ivonescimab is superior to stan...
Status
Recruiting
Location
CHU Amiens Picardie
Start Date
2025-10-09
Trial ID
NCT06529718
Treatments Being Tested
This is an open-label, multi-center study to evaluate the safety, tolerabil...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2021-11-03
Trial ID
NCT05099549